SCHEMBL12350155

SCHEMBL12350155

CC(=O)O/N=C(\CCCSc1ccc(Cl)cc1)C(=O)c1ccc(Sc2ccc(C(=O)c3ccccc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HDAC3 O15379 1/20 0.38
▸ HDAC4 P56524 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC7 Q8WUI4 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC11 Q96DB2 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ HDAC9 Q9UKV0 1/20 0.38
▸ HDAC5 Q9UQL6 1/20 0.38
▸ CES2 O00748 1/20 0.36
▸ CES1 P23141 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ HTT P42858 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21153924 0.97 HDAC1 (0.42) RAB9ANPC1MEN1KMT2AHDAC3
SCHEMBL2742396 0.94 HTT (0.39) RAB9ANPC1MEN1KMT2AHDAC3
SCHEMBL17069990 0.94 HTT (0.39) RAB9ANPC1MEN1KMT2AHDAC3
SCHEMBL17070004 0.89 HTT (0.37) RAB9AKMT2AHDAC1HDAC2ALDH1A1
SCHEMBL10262989 0.89 HTT (0.41) RAB9AMEN1KMT2AHDAC3HDAC4
SCHEMBL10144554 0.89 HTT (0.41) RAB9AMEN1KMT2AHDAC3HDAC4
SCHEMBL17069988 0.89 HTT (0.41) RAB9AMEN1KMT2AHDAC3HDAC4
SCHEMBL25014842 0.88 L3MBTL1 (0.40) KMT2ACES2CES1ALDH1A1L3MBTL1
SCHEMBL2742395 0.88 RAB9A (0.42) RAB9ANPC1MEN1KMT2AHDAC3
SCHEMBL12455466 0.88 CES2 (0.40) RAB9ANPC1MEN1KMT2ACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835081-B2 Polymerizable composition, color filter, method of producing color filter and solid-state image sensor FUJIFILM CORPORATION (JP) 2014-09-16 — — US disclosed
US-8835081-B2 Polymerizable composition, color filter, method of producing color filter and solid-state image sensor FUJIFILM CORPORATION (JP) 2014-09-16 — — US disclosed
US-8293436-B2 Oxime derivative, photopolymerizable composition, color filter, and process for producing the same FUJIFILM CORPORATION (JP) 2012-10-23 — — US disclosed
US-8293436-B2 Oxime derivative, photopolymerizable composition, color filter, and process for producing the same FUJIFILM CORPORATION (JP) 2012-10-23 — — US disclosed
US-20120236426-A1 POLYMERIZABLE COMPOSITION, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER AND SOLID-STATE IMAGE SENSOR FUJIFILM CORPORATION (JP) 2012-09-20 — — US disclosed
US-20120236426-A1 POLYMERIZABLE COMPOSITION, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER AND SOLID-STATE IMAGE SENSOR FUJIFILM CORPORATION (JP) 2012-09-20 — — US disclosed
US-20100104976-A1 OXIME DERIVATIVE, PHOTOPOLYMERIZABLE COMPOSITION, COLOR FILTER, AND PROCESS FOR PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2010-04-29 — — US disclosed
US-20100104976-A1 OXIME DERIVATIVE, PHOTOPOLYMERIZABLE COMPOSITION, COLOR FILTER, AND PROCESS FOR PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2010-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100104976-A1 OXIME DERIVATIVE, PHOTOPOLYMERIZABLE COMPOSITION, COLOR FILTER, AND PROCESS FOR PRODUCING THE SAME PPOX, CYBA, HBB RAB9A 4558/4885NPC1 4885/4885MEN1 4439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback